{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:15:49Z","timestamp":1791324949658,"version":"4.3.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004481","name":"University of Tehran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004481","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003968","name":"INSF","doi-asserted-by":"publisher","award":["96005880"],"award-info":[{"award-number":["96005880"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bbrep.2025.101995","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T11:45:47Z","timestamp":1744112747000},"page":"101995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Molecular modeling approach in design of new scaffold of \u03b1-glucosidase inhibitor as antidiabetic drug"],"prefix":"10.1016","volume":"42","author":[{"given":"Fatemeh","family":"Amini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khansa Ismaeal","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0380-8000","authenticated-orcid":false,"given":"Jahan B.","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2025.101995_bib1","article-title":"Discovery of new \u03b1-glucosidase inhibitors: structure-based virtual screening and biological evaluation","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.bbrep.2025.101995_bib2","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0140-6736(06)69703-1","article-title":"Epidemic obesity and type 2 diabetes in Asia","volume":"368","author":"Yoon","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bbrep.2025.101995_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1503\/cmaj.060244","article-title":"Type 1 diabetes: pathogenesis and prevention","volume":"157","author":"Gillespie","year":"2006","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.bbrep.2025.101995_bib4","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48479","article-title":"High fat diet induces microbiota-dependent silencing of enteroendocrine cells","volume":"8","author":"Ye","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.bbrep.2025.101995_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-99899-1","article-title":"Design, synthesis, biological evaluation, and molecular modeling studies of pyrazole-benzofuran hybrids as new \u03b1-glucosidase inhibitor","volume":"11","author":"Azimi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2025.101995_bib6","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1271\/bbb.61.1233","article-title":"Molecular mechanism in \u03b1-glucosidase and glucoamylase","volume":"61","author":"Chiba","year":"1997","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.bbrep.2025.101995_bib7","first-page":"729","article-title":"Novel carbohydrate-triazole derivatives as potential \u03b1-glucosidase inhibitors","volume":"18","author":"Zhang","year":"2020","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.bbrep.2025.101995_bib14","first-page":"33","article-title":"Strategy of computer-aided drug design","volume":"3","author":"Veselovsky","year":"2003","journal-title":"Curr. Drug Targets: Infect. Disord."},{"key":"10.1016\/j.bbrep.2025.101995_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99899-1","article-title":"Design, synthesis, biological evaluation, and molecular modeling studies of pyrazole-benzofuran hybrids as new \u03b1-glucosidase inhibitor","volume":"11","author":"Azimi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2025.101995_bib16","series-title":"Pharmaceutical Sciences: Breakthroughs in Research and Practice","first-page":"770","article-title":"Molecular docking challenges and limitations","author":"Ghasemi","year":"2017"},{"issue":"23","key":"10.1016\/j.bbrep.2025.101995_bib8","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.2174\/1381612825666190717104547","article-title":"Recent developments in alpha-glucosidase inhibitors for management of type-2 diabetes: an update","volume":"25","author":"Usman","year":"2019","journal-title":"Curr. Pharm. Des."},{"issue":"18","key":"10.1016\/j.bbrep.2025.101995_bib9","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1016\/j.bmcl.2017.08.035","article-title":"Quinazoline-1-deoxynojirimycin hybrids as high active dual inhibitors of EGFR and \u03b1-glucosidase","volume":"27","author":"Zhang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbrep.2025.101995_bib10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ejmech.2016.09.067","article-title":"Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential \u03b1-glucosidase inhibitors","volume":"125","author":"Wang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bbrep.2025.101995_bib11","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.bmcl.2016.04.071","article-title":"Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent \u03b1-glucosidase inhibitors","volume":"26","author":"Wang","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbrep.2025.101995_bib19","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved protein ligand docking using GOLD","volume":"52","author":"Verdonk","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.bbrep.2025.101995_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201800470","article-title":"Design and synthesis of novel cytotoxic indole\u2010thiosemicarbazone derivatives: biological evaluation and docking study","volume":"16","author":"Bakherad","year":"2019","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bbrep.2025.101995_bib18","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1021\/ci5000533","article-title":"Setting the record straight: the origin of the pharmacophore concept","volume":"54","author":"Guner","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrep.2025.101995_bib17","series-title":"Book Review: Microbial Inoculants in Sustainable Agricultural Productivity-Vol. II: Functional Application","author":"Singh","year":"2016"},{"key":"10.1016\/j.bbrep.2025.101995_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1166\/rits.2014.1016","article-title":"Molecular modeling: origin, fundamental concepts and applications using structure-activity relationship and quantitative structure-activity relationship","volume":"2","author":"Santos","year":"2014","journal-title":"Rev. Theor. Sci."},{"key":"10.1016\/j.bbrep.2025.101995_bib22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/14756366.2016.1241781","article-title":"3D QSAR studies, pharmacophore modeling, and virtual screening of diarylpyrazole\u2013 benzene sulfonamide derivatives as a template to obtain new inhibitors, using human carbonic anhydrase II as a model protein","volume":"32","author":"Entezari Heravi","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.bbrep.2025.101995_bib23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/(SICI)1521-3838(199910)18:4<329::AID-QSAR329>3.0.CO;2-V","article-title":"Improved alignment by weighted field fit in CoMFA of histamine H2 receptor agonistic imidazolyl propyl guanidines","volume":"18","author":"Dove","year":"1999","journal-title":"Quant. Struct.-Act. Relat."},{"issue":"1","key":"10.1016\/j.bbrep.2025.101995_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/molecules27010155","article-title":"In vitro evaluation of the anti-diabetic potential of aqueous acetone helichrysum petiolare extract (AAHPE) with molecular docking relevance in diabetes mellitus","volume":"27","author":"Akinyede","year":"2021","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.bbrep.2025.101995_bib25","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1021\/ct200196m","article-title":"An automated force field topology builder (ATB) and repository: version 1.0","volume":"7","author":"Malde","year":"2011","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.bbrep.2025.101995_bib26","series-title":"2024.0601 Chemical Computing Group ULC, 910-1010 Sherbrooke St. W., Montreal, QC H3A 2R7","year":"2024"},{"issue":"8","key":"10.1016\/j.bbrep.2025.101995_bib27","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1271\/bbb.61.1233","article-title":"Molecular mechanism in \u03b1-glucosidase and glucoamylase","volume":"61","author":"Chiba","year":"1997","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.bbrep.2025.101995_bib28","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/01.mpg.0000421414.95751.be","article-title":"Direct starch digestion by sucrase-isomaltase and maltase-glucoamylase","volume":"55","author":"Lin","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825000822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825000822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:16:11Z","timestamp":1749035771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580825000822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":26,"alternative-id":["S2405580825000822"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.101995","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular modeling approach in design of new scaffold of \u03b1-glucosidase inhibitor as antidiabetic drug","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.101995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101995"}}